Table 2.

Complications and outcomes of patients undergone autologous stem cell transplant

Patient no.	Age at AHSCT (years)	Interval between Dx and recurrence	Stem cell source	Liver toxicity (grade)	Renal toxicity (grade)	Other complications	Disease status after AHSCT	Time to recurrence or progression (months)	Outcome	LPSa
1	8.6	13	PBSCb	1	Nil	Nil	CRc	13	Died at D + 493	N/Ad
2	14.3	7	PBSC	1	Nil	Pulmonary TB	CR	N/A	Survives for 9.8 years	90
3	5.2	18	PBSC	4	2	Bacillus cereus sepsis, Cl. difficile colitis, VODe	CR	N/A	Survives for 9.4 years	80
4	3.9	6	PBSC	1	Nil	Otitis externa	SDf	8	Died at D + 299	N/A
5	6.4	13	PBSC	1	1	E. coli UTIg	CR	N/A	Survives for 6.0 years	90
6	6.9	25	PBSC	1	1	Upper GIBh	SD	4	Died at D + 293	N/A
7	3.4	11	BMi	2	Nil	Upper GIB	CR	N/A	Survives for 5.4 years	80
8	11.7	N/Ad	PBSC	4	2	Acute sensorineural hearing loss, subdural hematoma, Cl. difficile colitis, enterococcus UTI	CR	11	Died at D + 632	N/A
9	4.4	9	BM	2	1	Pseudomonas aeruginosa UTI	CR	N/A	Survives for 5.0 years	50
10	20	16	PBSC	4	4	E. coli sepsis, engraftment syndrome with ARDS, pleural effusion, pneumonia, pneumothorax, GIB, acute renal failure	CR	N/A	Died at D + 46	N/A
11	11.2	14	PBSC	4	1	Transient visual loss, VOD, seizure	CR	N/A	Survives for 1.8 years	90
12	11.8	29	PBSC	3	Nil	Norovirus GEj, pneumonia, early CMV infection	SD	4	Died at D + 249	N/A
13	2.7	9	BM	2	Nil	Cl. difficile colitis	CR	N/A	Survives for 1.2 years	80

^aLPS, Lansky-Karnofsky performance score; ^bPBSC, Peripheral blood stem cell; ^cCR, Complete remission; ^dN/A, Not applicable; ^eVOD, Hepatic veno-occlusive disease; ^fSD, Stable disease; ^gUTI, Urinary tract infection; ^hGIB, Gastro-intestinal bleeding; ⁱBM, Bone marrow; ^jGE, Gastro-enteritis